Hs-CRP may be associated with white blood cell count in metabolic syndrome patients treated with Ginkgo biloba

Atherosclerosis

Volumn 218, Issue 1, 2011, Pages 250-252

  Siegel, G ^a,b   Ermilov, E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Eosinophils; Ginkgo biloba; High sensitivity C reactive protein (hs CRP); Metabolic syndrome patients; Monocytes

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYCLIC AMP; CYCLIC GMP; EOSINOPHIL CATIONIC PROTEIN; GELATINASE B; GINKGO BILOBA EXTRACT; INTERLEUKIN 6; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; MYELOPEROXIDASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PROSTAGLANDIN F2 ALPHA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE MARKER; FEMALE; HUMAN; LETTER; LEUKOCYTE COUNT; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADULT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; GINKGO BILOBA; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; LEUKOCYTES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PLANT EXTRACTS; TIME FACTORS;

EID: 80052267875     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.05.007     Document Type: Letter

References (29)

1. Niccoli G., Sgueglia G.A., Conte M., et al. Eosinophil cationic protein and clinical outcome after bare metal stent implantation. Atherosclerosis 2011, 215:166-169.
2. Niccoli G., Schiavino D., Belloni F., et al. Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents. Eur Heart J 2009, 30:1340-1347.
3. Rittersma S.Z.H., Meuwissen M., van der Loos C.M., et al. Eosinophilic infiltration in restenotic tissue following coronary stent implantation. Atherosclerosis 2006, 184:157-162.
4. Köster R., Vieluf D., Kiehn M., et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet 2000, 356:1895-1897.
5. Zavalloni D., Bossi P., Rossi M.L., Gasparini G.L., Lisignoli V., Presbitero P. Inflammatory substrate with eosinophils may be present in bare-metal stent thrombosis. J Cardiovasc Med 2009, 10:942-943.
6. Niccoli G., Ferrante G., Cosentino N., et al. Eosinophil cationic protein: a new biomarker of coronary atherosclerosis. Atherosclerosis 2010, 211:606-611.
7. Siegel G., Schmidt A., Schäfer P., et al. The importance of scavenging reactive oxygen species in anti-aging medicine. Eng Life Sci 2009, 9:363-375.
8. Siegel G., Rodríguez M., Sauer F., et al. Nanotechnologic biosensor ellipsometry and biomarker pattern analysis in the evaluation of atherosclerotic risk profile. Biosens Bioelectron 2009, 24:1512-1517.
9. Siegel G., Buddecke E., Hofer H.W., Just S. Complementary cardio-cerebro-vascular disease prevention in patients with metabolic syndrome. Arterioscler Thromb Vasc Biol 2009, 29:e40-e41.
10. Siegel G., Ermilov E., Saunders R., Pries A.R., Malmsten M. Nanotechnologic point-of-care ellipsometric device for arteriosclerotic diseases. Arterioscler Thromb Vasc Biol 2010, 30:e210.
11. Rodríguez M., Ringstad L., Schäfer P., et al. Reduction of atherosclerotic nanoplaque formation and size by Ginkgo biloba (EGb 761) in cardiovascular high-risk patients. Atherosclerosis 2007, 192:438-444.
12. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004, 350:1387-1397.
13. Tsimikas S. In vivo markers of oxidative stress and therapeutic interventions. Am J Cardiol 2008, 101:34D-42D.
14. Hansson G.K. Inflammation atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
15. Klebanoff S.J. Myeloperoxidase: friend and foe. J Leukoc Biol 2005, 77:598-625.
16. Lusis A.J., Fogelman A.M., Fonarow G.C. Genetic basis of atherosclerosis: part II: clinical implications. Circulation 2004, 110:2066-2071.
17. Nomoto K., Oguchi S., Watanabe I., Kushiro T., Kanmatsuse K. Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein, matrix metalloproteinase-9 and soluble vascular-cell adhesion molecule-1. J Cardiol 2003, 42:201-206.
18. Schäfer P., Rodríguez M., Siegel G. Atherosclerosis, an inflammatory and fibro-proliferative disease. A prophylactic phytochemical approach with Ginkgo biloba (EGb 761). Atherosclerosis 2007, 195:419-422.
19. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol 1997, 82:291-295.
20. Pietta P.-G. Flavonoids as antioxidants. J Nat Prod 2000, 63:1035-1042.
21. Oda E., Kawai R. Comparison between high-sensitivity C-reactive protein (hs-CRP) and white blood cell count (WBC) as an inflammatory component of metabolic syndrome in Japanese. Intern Med 2010, 49:117-124.
22. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
23. Walter D.H., Fichtlscherer S., Sellwig M., Auch-Schwelk W., Schächinger V., Zeiher A.M. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. J Am Coll Cardiol 2001, 37:839-846.
24. Zairis M.N., Ambrose J.A., Manousakis S.J., et al. The impact of plasma levels of C-reactive protein, lipoprotein(a) and homocysteine on the long-term prognosis after successful coronary stenting: the global evaluation of new events and restenosis after stent implantation study. J Am Coll Cardiol 2002, 40:1375-1382.
25. Hoshida S., Nishino M., Takeda T., Tanouchi J., Yamada Y., Hori M. A persistent increase in C-reactive protein is a risk factor for restenosis in patients with stable angina who are not receiving statins. Atherosclerosis 2004, 173:285-290.
26. Ramharack A., Barkalow D., Spahr M.A. Dominant negative effect of TGF-β1 and TNF-α on basal and IL-6-induced lipoprotein(a) and apolipoprotein(a) mRNA expression in primary monkey hepatocyte cultures. Arterioscler Thromb Vasc Biol 1998, 18:984-990.
27. Satoh M., Shimoda Y., Maesawa C., et al. Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction. Int J Cardiol 2006, 109:226-234.
28. Lippi G., Guidi G. Lipoprotein(a): an emerging cardiovascular risk factor. Crit Rev Clin Lab Sci 2003, 40:1-42.
29. Lippi G., Targher G., Guidi G.C. Ginkgo biloba, inflammation and lipoprotein(a). Atherosclerosis 2007, 195:417-418.